Bain Capital Life Sciences Investors, LLC Crinetics Pharmaceuticals, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $489 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$16.49 - $27.64 $4.55 Million - $7.62 Million
275,857 Added 13.59%
2,305,558 $43 Million
Q4 2021

Feb 14, 2022
BUY
$19.35 - $28.41 $6.77 Million - $9.94 Million
350,000 Added 20.84%
2,029,701 $57.7 Million
Q2 2021

Aug 16, 2021
BUY
$15.9 - $21.15 $9.67 Million - $12.9 Million
608,273 Added 56.77%
1,679,701 $31.7 Million
Q2 2020

Aug 14, 2020
BUY
$13.04 - $23.23 $14 Million - $24.9 Million
1,071,428 New
1,071,428 $18.8 Million

Others Institutions Holding CRNX

# of Institutions
244
Shares Held
78.2M
Call Options Held
268K
Put Options Held
197K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.73B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email